Johnson & Johnson Launches VARIPULSE Pro in Europe

Johnson & Johnson has launched its VARIPULSE Pro cardiac ablation system in Europe, following CE Mark approval. This launch expands the availability of the innovative medical device designed for treating cardiac arrhythmias. The CE Mark signifies compliance with European safety and performance standards. The introduction of VARIPULSE Pro in the European market is expected to enhance treatment options for patients with heart rhythm disorders.